AP2377A - Benzimidazole derivatives. - Google Patents

Benzimidazole derivatives.

Info

Publication number: AP2377A
Authority: AP; ARIPO
Prior art keywords: benzimidazole derivatives; benzimidazole; derivatives
Prior art date: 2007-06-29

Application number

AP2009005089A

Other languages

English (en)

Other versions

AP2009005089A0 (en

Inventor

Christopher Scott Jones

GRECA Susan LA

Qifang Li

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-29

Filing date

2008-06-16

Publication date

2012-03-07

2008-06-16 Application filed by Pfizer filed Critical Pfizer

2009-12-31 Publication of AP2009005089A0 publication Critical patent/AP2009005089A0/en

2012-03-07 Application granted granted Critical

2012-03-07 Publication of AP2377A publication Critical patent/AP2377A/xx

Links

229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Oncology (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AP2009005089A 2007-06-29 2008-06-16 Benzimidazole derivatives. AP2377A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94728707P	2007-06-29	2007-06-29
US4164508P	2008-04-02	2008-04-02
PCT/IB2008/001575 WO2009004427A2 (en)	2007-06-29	2008-06-16	Benzimidazole derivatives

Publications (2)

Publication Number	Publication Date
AP2009005089A0 AP2009005089A0 (en)	2009-12-31
AP2377A true AP2377A (en)	2012-03-07

Family

ID=40161351

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2009005089A AP2377A (en)	2007-06-29	2008-06-16	Benzimidazole derivatives.

Country Status (45)

Country	Link
US (2)	US8148401B2 (es)
EP (1)	EP2170860B9 (es)
JP (2)	JP4567099B2 (es)
KR (1)	KR101143246B1 (es)
CN (1)	CN101687841B (es)
AP (1)	AP2377A (es)
AR (1)	AR067346A1 (es)
AU (1)	AU2008272641B2 (es)
BR (1)	BRPI0813412B8 (es)
CA (1)	CA2690953C (es)
CL (1)	CL2008001922A1 (es)
CO (1)	CO6160232A2 (es)
CR (1)	CR11150A (es)
CU (1)	CU23847B1 (es)
CY (2)	CY1118650T1 (es)
DK (1)	DK2170860T5 (es)
DO (1)	DOP2009000278A (es)
EA (1)	EA016888B1 (es)
EC (1)	ECSP099803A (es)
ES (1)	ES2609258T3 (es)
FR (1)	FR20C1038I2 (es)
GE (1)	GEP20125702B (es)
GT (1)	GT200900328A (es)
HN (1)	HN2008000974A (es)
HR (1)	HRP20161562T2 (es)
HU (2)	HUE030052T4 (es)
IL (1)	IL202420A (es)
LT (2)	LT2170860T (es)
MA (1)	MA31466B1 (es)
ME (1)	ME00962B (es)
MY (1)	MY148636A (es)
NI (1)	NI200900219A (es)
NL (1)	NL301057I2 (es)
NO (1)	NO2020027I1 (es)
NZ (1)	NZ581889A (es)
PA (1)	PA8785401A1 (es)
PE (2)	PE20121010A1 (es)
PL (1)	PL2170860T3 (es)
PT (1)	PT2170860T (es)
RS (1)	RS55395B9 (es)
SI (1)	SI2170860T1 (es)
TN (1)	TN2009000544A1 (es)
TW (1)	TWI371451B (es)
UY (1)	UY31164A1 (es)
WO (1)	WO2009004427A2 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2690953C (en)	2007-06-29	2012-10-02	Pfizer Inc.	Benzimidazole derivatives
AU2009289649B2 (en)	2008-09-03	2016-05-05	Biomarin Pharmaceutical Inc.	Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
US8835648B2 (en) *	2009-06-11	2014-09-16	Siena Biotech S.P.A.	Hedgehog pathway antagonists and therapeutic applications thereof
EA201270311A1 (ru)	2009-08-26	2012-09-28	Такеда Фармасьютикал Компани Лимитед	Конденсированное гетероциклическое производное и его применение
US10010439B2 (en)	2010-06-13	2018-07-03	Synerz Medical, Inc.	Intragastric device for treating obesity
US8628554B2 (en)	2010-06-13	2014-01-14	Virender K. Sharma	Intragastric device for treating obesity
US10420665B2 (en)	2010-06-13	2019-09-24	W. L. Gore & Associates, Inc.	Intragastric device for treating obesity
US9526648B2 (en)	2010-06-13	2016-12-27	Synerz Medical, Inc.	Intragastric device for treating obesity
US9056865B2 (en)	2010-10-20	2015-06-16	Pfizer Inc.	Pyridine-2-derivatives as smoothened receptor modulators
JP5452459B2 (ja)	2010-12-16	2014-03-26	株式会社Ｎｔｔドコモ	ホーム基地局及びハンドオーバ方法
US10059723B2 (en)	2011-02-28	2018-08-28	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
WO2012118782A1 (en)	2011-02-28	2012-09-07	Repligen Corporation	Histone deacetylase inhibitors
US8957066B2 (en)	2011-02-28	2015-02-17	Biomarin Pharmaceutical Inc.	Histone deacetylase inhibitors
WO2012122370A2 (en) *	2011-03-08	2012-09-13	Eutropics Pharmaceuticals, Inc.	Compositions and methods useful for treating diseases
FR2980477B1 (fr)	2011-09-23	2013-10-18	Centre Nat Rech Scient	Nouveaux composes modulateurs de la voie de signalisation des proteines hedgehog, leurs formes marquees, et applications
CN103814024B (zh) *	2011-09-26	2016-11-23	默克专利股份公司	作为溶血磷脂酸(lpa)受体拮抗剂的苄基哌啶化合物
EP2863920B1 (en)	2012-06-20	2023-03-22	Eutropics Pharmaceuticals, Inc.	Quinoline derivatives for use in the tratment of breast cancer
EP2922544B1 (en)	2012-11-21	2018-08-01	Eutropics Pharmaceuticals, Inc.	Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
RU2665554C2 (ru)	2013-03-15	2018-08-31	Байомарин Фармасьютикал Инк.	Ингибиторы hdac
EP2996689A1 (en) *	2013-04-17	2016-03-23	Albert-Ludwigs-Universität Freiburg	Compounds for use as bromodomain inhibitors
US10732182B2 (en)	2013-08-01	2020-08-04	Eutropics Pharmaceuticals, Inc.	Method for predicting cancer sensitivity
GB2519344A (en) *	2013-10-18	2015-04-22	Redx Pharma Ltd	Compounds
AU2014342269B2 (en)	2013-10-30	2020-02-27	Eutropics Pharmaceuticals, Inc.	Methods for determining chemosensitivity and chemotoxicity
EP3286176B1 (en) *	2015-04-24	2020-01-15	Pfizer Inc	Crystalline forms of 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea maleate
US10779980B2 (en)	2016-04-27	2020-09-22	Synerz Medical, Inc.	Intragastric device for treating obesity
JP7792189B2 (ja) *	2019-03-29	2025-12-25	デクセリアルズ株式会社	接着剤組成物
US12668581B2 (en)	2020-01-28	2026-06-30	Assia Chemical Industries Ltd.	Processes for the preparation of Glasdegib and salt thereof and solid state forms of Glasdegib maleate and process for preparation thereof
CN113248475B (zh) *	2020-02-11	2023-03-17	中国科学院上海药物研究所	一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途
WO2021191278A1 (en)	2020-03-26	2021-09-30	Lek Pharmaceuticals D.D.	Dimaleate form of 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)urea
EP4173639A4 (en)	2020-06-26	2024-03-13	RaQualia Pharma Inc.	METHOD FOR SELECTING A CANCER PATIENT FOR WHICH COMBINATION THERAPY OF A RETINOID AND A CANCER TREATMENT AGENT WILL BE EFFECTIVE, AND COMBINATION DRUG OF A RETINOID AND A CANCER TREATMENT AGENT
WO2023002362A1 (en)	2021-07-22	2023-01-26	Pfizer Inc.	Treatment of hematological malignancy

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003048154A1 (en) *	2001-12-04	2003-06-12	Actelion Pharmaceuticals Ltd	4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists
WO2006050506A1 (en) *	2004-11-03	2006-05-11	Curis, Inc.	Mediators of hedgehog signaling pathways, compositions and uses related thereto
WO2006124780A2 (en) *	2005-05-12	2006-11-23	Kalypsys, Inc.	Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA007339B1 (ru)	2001-07-27	2006-08-25	Кьюэрис, Инк.	Медиаторы путей передачи сигналов генами hedgehog, содержащие их композиции и способы применения указанных веществ
TW200304820A (en) *	2002-03-25	2003-10-16	Avanir Pharmaceuticals	Use of benzimidazole analogs in the treatment of cell proliferation
JP2006505570A (ja) *	2002-10-17	2006-02-16	アムジエン・インコーポレーテツド	ベンズイミダゾール誘導体およびそれのバニロイド受容体リガンドとしての使用
WO2005042495A1 (en)	2003-10-21	2005-05-12	Imclone Systems Incorporated	(benzimidazol-2-yl)-phenyl-phenyl-urea compounds and methods for inhibiting heparanase activity
WO2005042497A2 (en)	2003-10-28	2005-05-12	Vertex Pharmaceuticals, Incorporated	Benzimidazoles useful as modulators of ion channels
DE102005012875B4 (de)	2005-03-19	2006-11-16	Sanofi-Aventis Deutschland Gmbh	Verwendung von Amino substituierten 8-N-Benzimidazolen
WO2008064830A1 (en)	2006-11-27	2008-06-05	Ucb Pharma, S.A.	Bicyclic and heterobicyclic derivatives, processes for preparing them and their pharmaceutical uses
WO2008075196A1 (en)	2006-12-15	2008-06-26	Pfizer Products Inc.	Benzimidazole derivatives
CA2690953C (en)	2007-06-29	2012-10-02	Pfizer Inc.	Benzimidazole derivatives
EP2303275A4 (en)	2008-06-17	2012-05-09	Univ Duke	STANDARD RECEPTOR MODULATORS
CN102203067B (zh)	2008-08-25	2014-01-15	Irm责任有限公司	Hedgehog通路调节剂

2008
- 2008-06-16 CA CA2690953A patent/CA2690953C/en active Active
- 2008-06-16 JP JP2010514162A patent/JP4567099B2/ja active Active
- 2008-06-16 HR HRP20161562TT patent/HRP20161562T2/hr unknown
- 2008-06-16 CN CN200880022602XA patent/CN101687841B/zh active Active
- 2008-06-16 EP EP08762901.0A patent/EP2170860B9/en active Active
- 2008-06-16 SI SI200831707A patent/SI2170860T1/sl unknown
- 2008-06-16 BR BRPI0813412A patent/BRPI0813412B8/pt active IP Right Grant
- 2008-06-16 MY MYPI20095266A patent/MY148636A/en unknown
- 2008-06-16 RS RS20161132A patent/RS55395B9/sr unknown
- 2008-06-16 ES ES08762901.0T patent/ES2609258T3/es active Active
- 2008-06-16 PL PL08762901T patent/PL2170860T3/pl unknown
- 2008-06-16 ME MEP-2009-349A patent/ME00962B/me unknown
- 2008-06-16 KR KR1020107001991A patent/KR101143246B1/ko active Active
- 2008-06-16 AU AU2008272641A patent/AU2008272641B2/en active Active
- 2008-06-16 DK DK08762901.0T patent/DK2170860T5/en active
- 2008-06-16 PT PT87629010T patent/PT2170860T/pt unknown
- 2008-06-16 EA EA200971104A patent/EA016888B1/ru unknown
- 2008-06-16 GE GEAP200811622A patent/GEP20125702B/en unknown
- 2008-06-16 WO PCT/IB2008/001575 patent/WO2009004427A2/en not_active Ceased
- 2008-06-16 LT LTEP08762901.0T patent/LT2170860T/lt unknown
- 2008-06-16 HU HUE08762901A patent/HUE030052T4/en unknown
- 2008-06-16 NZ NZ581889A patent/NZ581889A/en unknown
- 2008-06-16 AP AP2009005089A patent/AP2377A/xx active
- 2008-06-19 PA PA20088785401A patent/PA8785401A1/es unknown
- 2008-06-19 US US12/142,119 patent/US8148401B2/en active Active
- 2008-06-20 UY UY31164A patent/UY31164A1/es active IP Right Grant
- 2008-06-25 HN HN2008000974A patent/HN2008000974A/es unknown
- 2008-06-27 CL CL2008001922A patent/CL2008001922A1/es unknown
- 2008-06-27 AR ARP080102792A patent/AR067346A1/es active IP Right Grant
- 2008-06-27 PE PE2012000473A patent/PE20121010A1/es active IP Right Grant
- 2008-06-27 PE PE2008001105A patent/PE20090772A1/es active IP Right Grant
- 2008-06-27 TW TW097124392A patent/TWI371451B/zh active
2009
- 2009-11-30 IL IL202420A patent/IL202420A/en active IP Right Grant
- 2009-12-07 CR CR11150A patent/CR11150A/es unknown
- 2009-12-08 DO DO2009000278A patent/DOP2009000278A/es unknown
- 2009-12-14 EC EC2009009803A patent/ECSP099803A/es unknown
- 2009-12-18 NI NI200900219A patent/NI200900219A/es unknown
- 2009-12-21 GT GT200900328A patent/GT200900328A/es unknown
- 2009-12-21 CU CU2009000225A patent/CU23847B1/es active IP Right Grant
- 2009-12-23 CO CO09147462A patent/CO6160232A2/es unknown
- 2009-12-25 TN TNP2009000544A patent/TN2009000544A1/fr unknown
- 2009-12-29 MA MA32454A patent/MA31466B1/fr unknown
2010
- 2010-08-04 JP JP2010175465A patent/JP2010280693A/ja active Pending
2012
- 2012-02-24 US US13/404,169 patent/US8431597B2/en active Active
2016
- 2016-12-14 CY CY20161101293T patent/CY1118650T1/el unknown
2020
- 2020-07-15 NL NL301057C patent/NL301057I2/nl unknown
- 2020-08-11 NO NO2020027C patent/NO2020027I1/no unknown
- 2020-08-12 CY CY2020028C patent/CY2020028I2/el unknown
- 2020-08-13 HU HUS2000031C patent/HUS2000031I1/hu unknown
- 2020-08-20 FR FR20C1038C patent/FR20C1038I2/fr active Active
- 2020-08-26 LT LTPA2020528C patent/LTC2170860I2/lt unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003048154A1 (en) *	2001-12-04	2003-06-12	Actelion Pharmaceuticals Ltd	4-(piperidyl- and pyrrolidyl-alkyl-ureido) -quinolines as urotensin ii receptor antagonists
WO2006050506A1 (en) *	2004-11-03	2006-05-11	Curis, Inc.	Mediators of hedgehog signaling pathways, compositions and uses related thereto
WO2006124780A2 (en) *	2005-05-12	2006-11-23	Kalypsys, Inc.	Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase

Also Published As

Publication number	Publication date
HK1139658A1 (en)	2010-09-24
NZ581889A (en)	2011-05-27
CN101687841A (zh)	2010-03-31
PT2170860T (pt)	2017-01-04
ECSP099803A (es)	2010-01-29
KR20100028120A (ko)	2010-03-11
EP2170860A2 (en)	2010-04-07
US20120157495A1 (en)	2012-06-21
CR11150A (es)	2010-02-08
AR067346A1 (es)	2009-10-07
JP2010280693A (ja)	2010-12-16
CN101687841B (zh)	2013-07-10
TWI371451B (en)	2012-09-01
ES2609258T3 (es)	2017-04-19
WO2009004427A3 (en)	2009-06-04
FR20C1038I2 (fr)	2021-08-13
HUE030052T2 (hu)	2017-04-28
CU23847B1 (es)	2012-10-15
BRPI0813412B1 (pt)	2020-01-21
RS55395B9 (sr)	2020-01-31
DK2170860T3 (en)	2017-01-09
SI2170860T1 (sl)	2017-01-31
GT200900328A (es)	2011-08-29
NL301057I1 (nl)	2020-07-22
US20090005416A1 (en)	2009-01-01
AU2008272641A1 (en)	2009-01-08
IL202420A0 (en)	2010-06-30
MY148636A (en)	2013-05-15
HRP20161562T1 (hr)	2016-12-30
CL2008001922A1 (es)	2009-01-02
BRPI0813412A2 (pt)	2014-12-30
FR20C1038I1 (es)	2020-10-02
US8148401B2 (en)	2012-04-03
JP2010531869A (ja)	2010-09-30
AU2008272641B2 (en)	2013-08-29
TN2009000544A1 (fr)	2011-03-31
KR101143246B1 (ko)	2012-05-18
NL301057I2 (nl)	2020-09-10
GEP20125702B (en)	2012-12-10
HN2008000974A (es)	2011-01-24
PA8785401A1 (es)	2009-01-23
CY1118650T1 (el)	2017-07-12
WO2009004427A2 (en)	2009-01-08
CY2020028I1 (el)	2020-11-25
CY2020028I2 (el)	2020-11-25
TW200911792A (en)	2009-03-16
CO6160232A2 (es)	2010-05-20
BRPI0813412B8 (pt)	2021-05-25
ME00962B (me)	2012-06-20
EP2170860B9 (en)	2017-02-22
UY31164A1 (es)	2009-01-30
JP4567099B2 (ja)	2010-10-20
IL202420A (en)	2014-05-28
CA2690953C (en)	2012-10-02
LTC2170860I2 (lt)	2022-03-10
CU20090225A7 (es)	2012-02-15
LT2170860T (lt)	2017-01-10
CA2690953A1 (en)	2009-01-08
HRP20161562T2 (hr)	2017-04-21
EP2170860B1 (en)	2016-11-02
RS55395B1 (sr)	2017-04-28
PL2170860T3 (pl)	2017-05-31
NO2020027I1 (no)	2020-08-11
HUS2000031I1 (hu)	2020-09-28
DK2170860T5 (en)	2017-03-20
LTPA2020528I1 (lt)	2020-09-25
AP2009005089A0 (en)	2009-12-31
NI200900219A (es)	2010-03-11
PE20090772A1 (es)	2009-06-24
US8431597B2 (en)	2013-04-30
PE20121010A1 (es)	2012-08-06
EA016888B1 (ru)	2012-08-30
MA31466B1 (fr)	2010-06-01
HUE030052T4 (en)	2017-06-28
DOP2009000278A (es)	2009-12-31
EA200971104A1 (ru)	2010-06-30

Publication	Publication Date	Title
HUS2000031I1 (hu)	2020-09-28	Benzimidazol-származékok
IL206765A0 (en)	2010-12-30	4,5-dihydro-oxazol-2-yl-amine derivatives
IL205759A0 (en)	2010-11-30	Isoxazolo-pyridine derivatives
IL205753A0 (en)	2010-11-30	Isoxazolo-pyridazine derivatives
IL202020A0 (en)	2010-06-16	Spiroindolinone derivatives
ZA201001058B (en)	2010-11-24	Quinazolinamide derivatives
IL205755A0 (en)	2010-11-30	Isoxazolo-pyrazine derivatives
ZA201000431B (en)	2011-12-28	Indazolamide derivatives
IL204683A0 (en)	2010-11-30	Imidazole derivatives
IL200618A0 (en)	2010-05-17	Aza-pyridopyrimidinone derivatives
AP2010005345A0 (en)	2010-08-31	Indazole derivatives.
IL209733A0 (en)	2011-02-28	New benzimidazole derivatives
IL202667A0 (en)	2010-06-30	Isoxazole-imidazole derivatives
IL193475A0 (en)	2009-05-04	Benzimidazole derivatives
EP2172454A4 (en)	2010-12-08	benzimidazole derivative
PL2245028T3 (pl)	2012-07-31	Pochodne 5-aminocyklilometyloksazolidyn-2-onu
EP2133347A4 (en)	2010-03-17	1-BIARYLAZETIDINONDERIVATE
IL202463A0 (en)	2010-06-30	Sulfonyl-quinoline derivatives
IL202159A0 (en)	2010-06-16	Piperidine-amide derivatives
IL211806A0 (en)	2011-06-30	New benzimidazole derivatives
ZA201002218B (en)	2010-12-29	Thiadiazinone derivatives
ZA200908626B (en)	2010-08-25	Benzimidazole Derivatives
AP2009005065A0 (en)	2009-12-31	Sulfonyl-quinoline derivatives
HU0700417D0 (en)	2007-08-28	Sulfonyl-quinoline derivatives
GB0702266D0 (en)	2007-03-14	7-Azaindoe derivatives